I agree that this site is using cookies. You can find further informations here.
X
O'Dwyer, Peter J.
309  results:
Search for persons X
?
1

Circulating KRAS G12D but not G12V is associated with survi..:

Till, Jacob E. ; McDaniel, Lee ; Chang, Changgee...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Combining antivascular endothelial growth factor and anti-e..:

Hochster, Howard S ; Catalano, Paul ; Weitz, Michelle...
JNCI: Journal of the National Cancer Institute.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

Targeting super-enhancers in refractory pancreatic cancer:

Propper, David ; Borazanci, Erkut ; Han, Haiyong...
Pancreatology.  23 (2023)  4 - p. e5 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Phase II Study of Palbociclib (PD-0332991) inCCND1,2, or3Am..:

Clark, Amy S. ; Hong, Fangxin ; Finn, Richard S....
Clinical Cancer Research.  29 (2023)  8 - p. 1477-1483 , 2023
Link: https://doi.org/10.1158/..
 
?
5

The NCI-MATCH trial: lessons for precision oncology:

O'Dwyer, Peter J. ; Gray, Robert J. ; Flaherty, Keith T....
Nature Medicine.  29 (2023)  6 - p. 1349-1357 , 2023
Link: https://doi.org/10.1038/..
 
?
6

Ibrutinib combination therapy for advanced gastrointestinal..:

Oh, Do-Youn ; Maqueda, Maria Alsina ; Quinn, David I....
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
7

The New NCI Precision Medicine Trials:

Harris, Lyndsay N. ; Blanke, Charles D. ; Erba, Harry P....
Clinical Cancer Research.  29 (2023)  23 - p. 4728-4732 , 2023
Link: https://doi.org/10.1158/..
 
?
8

Clinical and exploratory biomarker findings from the MODUL ..:

Ducreux, Michel ; Tabernero, Josep ; Grothey, Axel...
European Journal of Cancer.  184 (2023)  - p. 137-150 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Animal Models and Their Role in Imaging-Assisted Co-Clinica..:

Peehl, Donna M. ; Badea, Cristian T. ; Chenevert, Thomas L....
Tomography.  9 (2023)  2 - p. 657-680 , 2023
Link: https://doi.org/10.3390/..
 
?
10

National Cancer Institute Combination Therapy Platform Tria..:

Meric-Bernstam, Funda ; Ford, James M. ; O'Dwyer, Peter J....
Clinical Cancer Research.  29 (2023)  8 - p. 1412-1422 , 2023
Link: https://doi.org/10.1158/..
 
?
11

The GIANT trial (ECOG-ACRIN EA2186) methods paper: A random..:

Dotan, Efrat ; Catalano, Paul ; Lenchik, Leon...
Journal of Geriatric Oncology.  14 (2023)  3 - p. 101474 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in pa..:

El-Khoueiry, Anthony B. ; Clarke, James ; Neff, Tobias...
British Journal of Cancer.  129 (2023)  2 - p. 309-317 , 2023
Link: https://doi.org/10.1038/..
 
?
13

Phase I Study of Glesatinib (MGCD265) in Combination with E..:

Patnaik, Amita ; Gadgeel, Shirish ; Papadopoulos, Kyriakos P....
Targeted Oncology.  17 (2022)  2 - p. 125-138 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Correction to: Phase I Study of Glesatinib (MGCD265) in Com..:

Patnaik, Amita ; Gadgeel, Shirish ; Papadopoulos, Kyriakos P....
Targeted Oncology.  17 (2022)  2 - p. 139-139 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Phase I Trial of Regorafenib, Hydroxychloroquine, and Entin..:

Karasic, Thomas B ; Brown, Timothy J ; Schneider, Charles...
The Oncologist.  27 (2022)  9 - p. 716-e689 , 2022
Link: https://doi.org/10.1093/..
 
1-15